Overview and Scope
The keytruda market consists of sales of immunotherapy, combination therapies, clinical trials, and personalized medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Sizing and Forecast
The keytruda market size has grown strongly in recent years. It will grow from $19.71 billion in 2023 to $21.60 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to improved patient outcomes, increased adoption of immunotherapy, increased research and development, improved patient compliance, and increased adoption of keytruda.
The keytruda market size is expected to see strong growth in the next few years. It will grow to $31.52 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to expanding indications, emerging markets, increasing prevalence of cancer, rising healthcare expenditure, and growing demand for precision medicine. Major trends in the forecast period include demand for targeted therapies, advances in immunotherapy, advances in diagnostic technologies, demand for cancer treatment, and advances in cancer research.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/keytruda-global-market-report
Segmentation & Regional Insights
The keytruda market covered in this report is segmented –
1) By Cancer Type: Melanoma, Lung Cancer, Head And Neck Cancer, Hodgkin Lymphoma, Stomach Cancer, Urothelial Carcinoma
2) By Payer Type: Commercial, Medicare, Medicaid
3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies
North America was the largest region in the keytruda market in 2023. The regions covered in the keytruda market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16457&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cancer is expected to propel the growth of the keytruda market going forward. Cancer is a complex group of diseases characterized by the abnormal growth and spread of cells. The prevalence of cancer is due to genetic factors, lifestyle factors, environmental factors, and hormonal factors. Keytruda (pembrolizumab) helps in cancer treatment primarily by harnessing the body’s immune system to fight cancer cells more effectively. It represents a significant advancement in cancer treatment by harnessing the power of the immune system to target and attack cancer cells, providing new hope for many patients with advanced or metastatic cancers. For instance, in May 2021, according to the National Library of Medicine, a US-based medicine library, the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020. Therefore, the increasing prevalence of cancer drives the keytruda market.
Key Industry Players
Major companies operating in the keytruda market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Chugai Pharmaceutical Co. Ltd., BioNTech AG, Organon Co., Ono Pharmaceutical Co. Ltd., Samsung Bioepis Co. Ltd., Fate Therapeutics Inc., Merck Sharp & Dohme Corp., KinBio, Schering-Plough AB, LGM Pharma LLC, Gritstone Bio Inc.
The keytruda market report table of contents includes:
- Executive Summary
- Keytruda Market Characteristics
- Keytruda Market Trends And Strategies
- Keytruda Market – Macro Economic Scenario
- Global Keytruda Market Size and Growth
………..
- Global Keytruda Market Competitive Dashboard
- Key Mergers And Acquisitions In The Keytruda Market
- Keytruda Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Keytruda Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Keytruda Market, Segmentation By Payer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Keytruda Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…….
Table 74: Pfizer Inc. Financial Performance
Table 75: Johnson & Johnson Services Inc. Financial Performance
Table 76: Roche Holding AG Financial Performance
Table 77: Merck & Co. Inc. Financial Performance
Table 78: AbbVie Inc. Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/veterinary-rehabilitation-services-market-report/
https://topprnews.com/virtual-kitchen-market-share/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
